We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Chen Mao - Principal Scientist (Technology), Small Molecule Pharmaceutical Sciences

Chen Mao

Principal Scientist (Technology), Small Molecule Pharmaceutical Sciences

"I consider it a great privilege to work with so many talented scientists with immensely diverse background, yet all laser focused toward the same goal – to discover and develop best possible medicinal products for patients."
Years at Genentech
Publications at Genentech

I joined Genentech in 2013 as a Scientist in the Small Molecule Pharmaceutical Sciences department. My primary focus is the development of solid dosage formulations for small molecule drugs. I’m also interested in applying modeling to facilitate material and process understanding in formulation development. I was drawn to Genentech because of its long-standing tradition: unwavering dedication to science and empowerment of scientists in pursuit of best medicines for patients.

Featured Publication

Solubility Advantage (and Disadvantage) of Pharmaceutical Amorphous Solid Dispersions.

J Pharm Sci. 2016 Dec;105(12):3549-3561.

Huang S, Mao C, Williams RO 3rd, Yang CY.